Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 213,808 | 220,382 | 167,413 | 217,127 | 165,526 |
| Cost of Goods | 12,731 | 14,144 | 10,893 | 14,011 | 9,639 |
| Gross Profit | 201,077 | 206,238 | 156,520 | 203,116 | 155,887 |
| Operating Expenses | 411,351 | 323,997 | 357,751 | 271,314 | 248,888 |
| Operating Income | -209,543 | -117,615 | -200,338 | -68,187 | -92,362 |
| Interest Expense | 29,415 | 27,331 | 24,501 | 20,880 | 21,976 |
| Other Income | 1,479 | 9,956 | 35,146 | -38,141 | -34,357 |
| Pre-tax Income | -237,479 | -134,990 | -189,693 | -127,208 | -148,695 |
| Income Tax | -38,596 | 3,969 | -18,804 | -17,893 | 3,392 |
| Net Income Continuous | -198,883 | -138,959 | -170,889 | -109,315 | -152,087 |
| Net Income | $-198,883 | $-138,959 | $-170,889 | $-109,315 | $-152,087 |
| EPS Basic Total Ops | -2.66 | -1.88 | -2.35 | -1.53 | -2.13 |
| EPS Basic Continuous Ops | -2.66 | -1.88 | -2.36 | -1.53 | -2.13 |
| EPS Diluted Total Ops | -2.66 | -1.88 | -2.35 | -1.53 | -2.13 |
| EPS Diluted Continuous Ops | -2.66 | -1.88 | -2.36 | -1.53 | -2.13 |
| EBITDA(a) | $59,822 | $-74,437 | $-127,583 | $-33,077 | $-62,058 |